Eurobio Scientific has been listed on Euronext Growth Paris (ALERS) since 2005 and is part of the Euronext Growth BPI innovation and Next Biotech indices. It is one of the stock with the highest liquidity on Euronext Growth.
|
Euronext Growth
|
|
|
|
||
|
Industry: Healthcare (4000) |
|
|
|
||
|
FR0013240934 ALERS: FP ALERS.PA
414 488 171 00045 FR 88 414 488 171 |
|
|
|
||
|
November 17, 2005 |
|
|
|
||
|
€ 3,629,814.72 |
|
|
|
||
|
11,343,171 shares with nominal value € 0,32 Changes in Share capital (in French) |
|
|
|
||
|
To the company’s knowledge, the share capital of Eurobio-Scientific on June 30, 2021 was structured as shown below : |
|
| Shareholders | Share Capital | Voting rights | ||
|---|---|---|---|---|
| Number | % | Nombre | % | |
| Jean-Michel Carle Grandmougin | 1,594,208 | 14.05 | 1,594,208 | 14.70 |
| Denis Fortier | 1,650,245 | 14.55 | 1,650,245 | 15,22 |
| Other Management, supervisory board members, and Employees | 885,877 | 3.40 | 885,877 | 3.56 |
| Investment funds (disclosed shareholding) | 236,712 | 2.09 | 236,712 | 2.18 |
| Treasury Shares | 499,756 | 4.41 | 0 | 0 |
| Other funds and general public | 6,976,373 | 61.50 | 6,976,373 | 64.34 |
Total |
11,343,171 |
100.00 |
10,843,415 |
100.00 |